Chun Chao to Papillomavirus Infections
This is a "connection" page, showing publications Chun Chao has written about Papillomavirus Infections.
Connection Strength
5.365
-
Primary Human Papillomavirus Screening: Women's Perceptions of New Cervical Cancer Screening Recommendations. J Womens Health (Larchmt). 2024 Dec; 33(12):1614-1624.
Score: 0.841
-
A study protocol for a cluster randomized pragmatic trial for comparing strategies for implementing primary HPV testing for routine cervical cancer screening in a large health care system. Contemp Clin Trials. 2023 01; 124:106994.
Score: 0.740
-
Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. Vaccine. 2022 11 02; 40(46):6575-6580.
Score: 0.735
-
Gaps in the screening process for women diagnosed with cervical cancer in four diverse US health care settings. Cancer Med. 2023 Feb; 12(3):3705-3717.
Score: 0.733
-
Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb; 216(2):151.e1-151.e9.
Score: 0.486
-
A randomized intervention of reminder letter for human papillomavirus vaccine series completion. J Adolesc Health. 2015 Jan; 56(1):85-90.
Score: 0.425
-
Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc. 2009 Oct; 84(10):864-70.
Score: 0.298
-
Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am J Public Health. 2009 Jun; 99(6):1137-42.
Score: 0.289
-
Effectiveness of 'catch-up' human papillomavirus vaccination to prevent cervical neoplasia in immunosuppressed and non-immunosuppressed women. Vaccine. 2020 06 15; 38(29):4520-4523.
Score: 0.156
-
Postlicensure safety surveillance of congenital anomaly and miscarriage among pregnancies exposed to quadrivalent human papillomavirus vaccine. Hum Vaccin Immunother. 2018 02 01; 14(2):412-419.
Score: 0.132
-
Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
Score: 0.124
-
Human papillomavirus vaccine series completion: Qualitative information from providers within an integrated healthcare organization. Vaccine. 2016 06 24; 34(30):3515-21.
Score: 0.116
-
Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example. Vaccine. 2015 Nov 17; 33(46):6224-6.
Score: 0.113
-
Evaluation of autoimmune safety signal in observational vaccine safety studies. Hum Vaccin Immunother. 2012 Sep; 8(9):1302-4.
Score: 0.091
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.
Score: 0.086